|
|
Post by MnkdWASmyRtrmntPlan on Sept 27, 2022 12:24:59 GMT -5
So if he’s so great and was doing tremendous work with Mike, and then was poached as a CEO, then it is still a negative for MannKind. Any examples of this tremendous work he did? Ha, as you said yourself, Mango, he used his MNKD jobs as stepping stones to a CEO gig. That's pretty darn good (you might even say "tremendous") work. It's certainly better than any work I have ever done, and probably better than most of us here. |
|
|
|
Post by mango on Sept 27, 2022 12:40:21 GMT -5
Any examples of this tremendous work he did? Ha, as you said yourself, Mango, he used his MNKD jobs as stepping stones to a CEO gig. That's pretty darn good (you might even say "tremendous") work. It's certainly better than any work I have ever done, and probably better than most of us here. It’ll certainly be interesting to find out if it’s a large, well known reputable company or a small company that no one has ever heard of. Kind of like when Kendall left for Zealand. Almost was a step down, no? Or could have been a side step or even a step up. That’s the beauty with reality, it’s subjective! |
|
|
|
Post by mytakeonit on Sept 27, 2022 12:41:29 GMT -5
Exactly ... and now we wait for the next MNKD quarterly report and the developments with UTHR.
But, that's mytakeonit
|
|
|
|
Post by neil36 on Sept 27, 2022 14:01:08 GMT -5
Ha, as you said yourself, Mango, he used his MNKD jobs as stepping stones to a CEO gig. That's pretty darn good (you might even say "tremendous") work. It's certainly better than any work I have ever done, and probably better than most of us here. It’ll certainly be interesting to find out if it’s a large, well known reputable company or a small company that no one has ever heard of. Kind of like when Kendall left for Zealand. Almost was a step down, no? Or could have been a side step or even a step up. That’s the beauty with reality, it’s subjective! hmmmmm.....in the spirit of wild speculation, what if Galindo is leaving to become CEO of a small company MC intends to purchase, using the Kendall/Zealand model?  |
|
|
|
Post by cretin11 on Sept 27, 2022 14:24:32 GMT -5
It’ll certainly be interesting to find out if it’s a large, well known reputable company or a small company that no one has ever heard of. Kind of like when Kendall left for Zealand. Almost was a step down, no? Or could have been a side step or even a step up. That’s the beauty with reality, it’s subjective! hmmmmm.....in the spirit of wild speculation, what if Galindo is leaving to become CEO of a small company MC intends to purchase, using the Kendall/Zealand model? That does fit the "wild speculation" category, and please please let it not be true. Bad enough that AG is leaving, as it is. |
|
|
|
Post by akemp3000 on Sept 27, 2022 14:43:39 GMT -5
Looks like the market had no reaction to the announcement of AG leaving. Appears all of the reaction is here  |
|
|
|
Post by cedafuntennis on Sept 27, 2022 15:17:48 GMT -5
Or the reaction was in the 33% drop in the week prior to the announcement as with MNKD it looks like a select few are tipped in advance of us sheep.
|
|
|
|
Post by mango on Sept 27, 2022 15:32:07 GMT -5
Or the reaction was in the 33% drop in the week prior to the announcement as with MNKD it looks like a select few are tipped in advance of us sheep. If you look at the charts MNKD dropped when XBI dropped around Sept 14. MNKD of course dropped harder but it’s been following it’s steep downward trajectory since around Sept. 14. The week prior to this announcement we did not drop 33% I don’t think. Past 5 days was something like 12%. Past month wasn’t 33% either and likely people knew way in advance about AG leaving than just a week ago. This kind of move doesn’t happen overnight and people talk. |
|
|
|
Post by cedafuntennis on Sept 28, 2022 10:29:11 GMT -5
Or the reaction was in the 33% drop in the week prior to the announcement as with MNKD it looks like a select few are tipped in advance of us sheep. If you look at the charts MNKD dropped when XBI dropped around Sept 14. MNKD of course dropped harder but it’s been following it’s steep downward trajectory since around Sept. 14. The week prior to this announcement we did not drop 33% I don’t think. Past 5 days was something like 12%. Past month wasn’t 33% either and likely people knew way in advance about AG leaving than just a week ago. This kind of move doesn’t happen overnight and people talk. well, do the math. A few days ago we were around 4.07 then dropped to 2.97 or so. How much is that? |
|
|
|
Post by akemp3000 on Sept 28, 2022 12:21:51 GMT -5
And now we're currently above $3.10. Guess the market liked AG leaving |
|
|
|
Post by phdedieu12 on Sept 28, 2022 12:33:21 GMT -5
Do you truly believe that the market cares that much about employees coming and going?? And isn't part of corporate America do have mobility, especially at the C suite level??
|
|
|
|
Post by nxc2 on Sept 28, 2022 13:32:50 GMT -5
Quanta Appoints Alejandro Galindo as Chief Executive Officer www.einnews.com/pr_news/592936285/quanta-appoints-alejandro-galindo-as-chief-executive-officerNEWS PROVIDED BY Quanta Dialysis Technologies September 28, 2022, 12:45 GMT SHARE THIS ARTICLE Quanta appoints Alejandro Galindo as its next CEO Unanimous Endorsement of MannKind Executive Follows Extensive Search BEVERLY, MASSACHUSETTS, USA, September 28, 2022 /EINPresswire.com/ -- Quanta Dialysis Technologies® Ltd (“Quanta” or the “Company”), a medical technology company committed to making kidney care more accessible with its Quanta™ Dialysis System, today announced that its Board of Directors has unanimously elected Alejandro Galindo, M.B.A., M.S. as the organization’s next chief executive officer (CEO). Mr. Galindo succeeds Interim CEO, Hooman Hakami, who will return to his role on the Board effective October 31, 2022. “On behalf of the Board, I am pleased to welcome Alejandro as Quanta’s next CEO,” said Chairman of Quanta’s Board, Johan de Ruiter. “After undergoing an extensive search process, we are confident we have the right individual for the role. Alejandro is an inspiring leader. His proven experience driving strategic transformation in the healthcare industry well positions him to accelerate Quanta’s growth and generate value for all of our stakeholders. We also thank Hooman for stepping in as interim CEO during the search, bringing invaluable leadership, and ensuring a seamless transition.” Mr. Galindo joins Quanta with over 25 years of experience in the healthcare, energy, and consumer industries. A career veteran known for his considerable expertise across a variety of leadership roles, Mr. Galindo has an accomplished track record in product development, mergers and acquisitions, global expansion, and distribution strategies. Most recently, he served as executive vice president of the Endocrine Business Unit of MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases. “I appreciate the confidence that the Board has placed in me and am honored to be appointed CEO. We are a purpose-driven organization, dedicated to making dialysis care accessible to every patient in every setting,” said Mr. Galindo. “It is a privilege for me to join Quanta as it addresses healthcare inequities through the development of transformative innovations which put the patient first. There is tremendous potential in Quanta and I look forward to working with Hooman, the Board, and the executive leadership team – and learning from our employees, patients, and commercial partners – as we continue to achieve our vision and lead the company into its next chapter.” Prior to MannKind, Mr. Galindo spent six years at Medtronic as vice president and president of the Advanced Insulin Management Business Unit, where he achieved double-digit growth within their diabetes division. Mr. Galindo also spent 20 years at General Electric leading teams across the globe from the company’s diverse group of industries. He holds a Master of Science and Master of Business Administration from Indiana University Bloomington and a Bachelor of Science in Engineering from Tecnologico de Monterrey. About Quanta Quanta Dialysis Technologies is committed to making dialysis accessible to every patient in every setting with its Quanta Dialysis System. As a portable device with performance comparable to larger, traditional machines, the Quanta Dialysis System is a modular and powerful solution that provides the clinical versatility needed to deliver dialysis care across multiple settings. With a simple-to-use and intuitive user interface, it is designed to be operated by a broad range of users to bring dialysis directly to patients. The Quanta Dialysis System is commercially available in the United Kingdom for home and hospital use and in the United States, it is FDA-cleared (K210661) for use in chronic and acute care settings. It is not cleared for home or nocturnal use in the United States. To learn more about Quanta and its products, visit www.quantadt.com. ### Melinda L Freson Quanta Dialysis Technologies +1 978-905-4893 press@quantadt.com Visit us on social media: LinkedIn Facebook |
|
|
|
Post by cretin11 on Sept 28, 2022 14:01:06 GMT -5
Good for AG, possibly good for Quanta, not good for MNKD. Wish we’d been able to keep him longer.
|
|
|
|
Post by akemp3000 on Sept 28, 2022 14:19:48 GMT -5
There seems to be a lot of speculative reasons why it's good or bad that he left. They're all possibilities. We may never know the truth or even whether it was good or bad for Mannkind. Hopefully, the replacement will be good for the company. Oh well. Onward and upward.
|
|
|
|
Post by nxc2 on Sept 28, 2022 14:22:00 GMT -5
Quanta thought enough to highlight MNKD in 2nd line of press release - I guess that is positive!
Quanta appoints Alejandro Galindo as its next CEO
Unanimous Endorsement of MannKind Executive Follows Extensive Search
|
|
